Dent Neurologic

DENTNeuro_White

DENT Neurosciences Research Center

The Dent Neuroscience Research Center (DNRC) is a 501(c)(3) not-for-profit affiliate of DENT dedicated to outcomes research and education supported by foundations, industry and personal contributions. The DNRC is focused on developing comprehensive, clinically relevant, and cost effective solutions to complex neurological problems faced in our community.

Building awareness, fostering relationships, providing support and continuous education are at the forefront of the DENT philosophy. From providing our patients with the most up-to-date diagnostic and treatment options to assisting each in the best care and coping opportunities, we aim to fulfill the needs of the whole patient. Through foundation support and exceptional faculty leadership, DNRC is able to build upon the philosophy by providing advancement, support and education to our providers and partners.

Open Studies

Want to participate in a study?

Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

  • All
  • ALS
  • Alzheimer's
  • Behavioral Health
  • Dizziness and Balance
  • Epilepsy
  • Headache/Migraine
  • Multiple Sclerosis
  • Parkisons Disease
  • Stroke Center
  • Treatment-Resistant Depression
  • Uncategorized
All
  • All
  • ALS
  • Alzheimer's
  • Behavioral Health
  • Dizziness and Balance
  • Epilepsy
  • Headache/Migraine
  • Multiple Sclerosis
  • Parkisons Disease
  • Stroke Center
  • Treatment-Resistant Depression
  • Uncategorized
Multiple Sclerosis

CogMS

CogMS – A Real-world Study Into Cognitive Impairment in People …

Read More →
Research Study

Generation HD-2

Generation HD-2 This study will evaluate the safety, biomarkers, and …

Read More →
Research Study

Intuition

Intuition – A Brain Health Study Intuition is a virtual …

Read More →
Alzheimer's

ENVISION

ENVISION Trial  The objective of this study is to verify …

Read More →
Multiple Sclerosis

CALLIPER

CALLIPER Phase 2 CALLIPER trial of lead asset IMU-838, the …

Read More →
Parkisons Disease

PROSEEK

PROSEEK To Potentially Help Slow Progression for People with Early-stage …

Read More →
Alzheimer's

Signal – AD

Signal- AD Trial The purpose of the study is to …

Read More →
Uncategorized

NRX- 101

Testing the hypothesis that treatment with NRX-101 is superior to standard of care (lurasidone) in improving symptoms of depression as measured by the total Montgomery Åsberg Depression Rating Scale (MADRS-10) score in patients with bipolar depression and subacute suicidal ideation and behavior (SSIB) which does not require hospitalization.

Read More →
Alzheimer's

ADNI4 Trial

ADNI4 Trial The ADNI4 is multi-center, a non-randomized, natural history, …

Read More →
Multiple Sclerosis

Descartes-08

Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis

Read More →
Alzheimer's

ADNI3 Trial

ADNI3 Trial Dent is taking part in an observational study …

Read More →
Dizziness and Balance

Hearing Aid Research

Hearing Aid Research Are you interested in participating in hearing …

Read More →
Dizziness and Balance

Meniere’s Study

Meniere’s Study Have you been diagnosed with Meniere’s Disease? Do …

Read More →
Uncategorized

Central Nervous System Effects Following Infusion of Diphenhydramine Using Pharmacokinetic and Pharmacodynamic Modeling

Central Nervous System Effects Following Infusion of Diphenhydramine Using Pharmacokinetic and Pharmacodynamic …

Read More →
Epilepsy

STARS and STARS Extension

Studies to Assess the Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

Read More →
ALS

MT-1186-A02

Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS

Read More →
Multiple Sclerosis

EMBOLD

Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis

Read More →
Multiple Sclerosis

FENTREPID

A Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Participants With Primary Progressive Multiple Sclerosis

Read More →
Parkisons Disease

PADOVA

A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson’s Disease

Read More →
Alzheimer's

RETHINK-ALZ

Simufilam 100 mg for Mild to Moderate Alzheimer’s Disease

Read More →
Treatment-Resistant Depression

RECOVER VNS

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Read More →

Subscribe To Our Newsletter

Sign up to receive email updates on announcements, new services added, company updates & more!

Research at Dent

The mission of research at DENT is to advance patient care by integrating the newest scientific advances into daily clinical practice. With support from organizations such as the Dent Family Foundation, the Blaszczykiewicz Foundation, and pharmaceutical clinical trials, DENT has established an impressive portfolio of publications and presentations in the scientific and clinical community.

Participating in research and clinical trials often provides an opportunity for patients to receive free medical care and medication. To learn if you might qualify, please visit Current Research Studies.

For research sponsors and investigators, we offer the opportunity to partner with an experienced team of researchers engaged in cutting-edge clinical practice and research in a wide variety of neurological disciplines.

Past & current research studies:

  • ALS (Lou Gehrig’s Disease)
  • Alzheimer’s Disease
  • Epilepsy
  • Memory Loss/Dementia
  • Migraine
  • Multiple Sclerosis
  • Neuroimaging
  • Neuro-oncology
  • Neuropathic Pain
  • Nuclear Medicine
  • Parkinson’s Disease
  • Psychiatry
  • Stroke
  • Vertigo

Giving Opportunities

The DNRC is funded through industry grants and clinical trial contracts, foundations, and community donations. Funds support need-based deserving initiatives related to the diagnosis and treatment of neurological disorders in patients from around the Western New York region.

Corporate or individual donors are welcome to designate their contribution to a specific specialty fund or have it applied to the general operating needs where it is most effective. Gifts can be made in many forms, including cash donations, proceeds from community benefits, corporate contributions and matching gifts, grants, planned gifts, gifts of honor or memorials, and more.

Please contact Maria Caserta, mcaserta@dentinstitute.com, to find out more about how you can help support our mission to bring the most comprehensive treatments to our neighbors and their families suffering with neurological disorders.

DNRC

Leadership

- Laszlo Mechtler, MD, Chief Medical Officer

- Fran M. Gengo, Pharm.D., Chief Science Officer

- Michelle Rainka, Pharm.D., CCRP, Secretary

- Joseph V. Fritz, Ph.D., Chief Administrative Executive

- Harry M. Dent III, Community Representative

- Maureen Tomczak-Griffin, Community Representative

- Anthony Baynes, Community Representative

The goal of DNRC is to advance neurologic care through pragmatic research and education at local, national and international levels.

Past Studies

Scroll to Top